DE1617299C3 - Glycopeptid-Antibiotikum AV 290 - Komplex (Avoparcin) Verfahren zu seiner Herstellung und seine Verwendung - Google Patents

Glycopeptid-Antibiotikum AV 290 - Komplex (Avoparcin) Verfahren zu seiner Herstellung und seine Verwendung

Info

Publication number
DE1617299C3
DE1617299C3 DE1617299A DE1617299A DE1617299C3 DE 1617299 C3 DE1617299 C3 DE 1617299C3 DE 1617299 A DE1617299 A DE 1617299A DE 1617299 A DE1617299 A DE 1617299A DE 1617299 C3 DE1617299 C3 DE 1617299C3
Authority
DE
Germany
Prior art keywords
antibiotic
avoparcin
complex
μπι
agar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1617299A
Other languages
German (de)
English (en)
Other versions
DE1617299B2 (de
DE1617299A1 (de
Inventor
John Norman Ramsey N.Y. Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE1617299A1 publication Critical patent/DE1617299A1/de
Publication of DE1617299B2 publication Critical patent/DE1617299B2/de
Application granted granted Critical
Publication of DE1617299C3 publication Critical patent/DE1617299C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/51—Streptomyces candidus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/892—Streptomyces candidus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE1617299A 1966-07-29 1967-07-29 Glycopeptid-Antibiotikum AV 290 - Komplex (Avoparcin) Verfahren zu seiner Herstellung und seine Verwendung Expired DE1617299C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US568881A US3338786A (en) 1966-07-29 1966-07-29 Antibiotic av290 and production thereof

Publications (3)

Publication Number Publication Date
DE1617299A1 DE1617299A1 (de) 1970-03-19
DE1617299B2 DE1617299B2 (de) 1981-04-23
DE1617299C3 true DE1617299C3 (de) 1982-05-13

Family

ID=24273108

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1617299A Expired DE1617299C3 (de) 1966-07-29 1967-07-29 Glycopeptid-Antibiotikum AV 290 - Komplex (Avoparcin) Verfahren zu seiner Herstellung und seine Verwendung

Country Status (5)

Country Link
US (1) US3338786A (enExample)
DE (1) DE1617299C3 (enExample)
FR (1) FR6697M (enExample)
GB (1) GB1194365A (enExample)
MY (1) MY7400019A (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832462A (en) * 1970-11-03 1974-08-27 American Cyanamid Co Antibiotic av290-syntan complexes and animal feed supplements
IE35741B1 (en) * 1970-11-03 1976-05-12 American Cyanamid Co Antibiotic av290-syntan complexes
US3855410A (en) * 1972-05-04 1974-12-17 American Cyanamid Co Method for the production and isolation of antibiotic av290 sulfate
US3950515A (en) * 1973-04-27 1976-04-13 American Cyanamid Company Animal feeds containing antibiotic AV290
DD114342A5 (enExample) * 1973-04-27 1975-08-05
AU517210B2 (en) * 1976-11-29 1981-07-16 American Cyanamid Company Control of swine dysentery with av290
US4259320A (en) * 1979-03-02 1981-03-31 American Cyanamid Company Concurrent use of avoparcin with growth-promoting implants in cattle
US4537770A (en) * 1982-03-24 1985-08-27 Eli Lilly And Company A41030 antibiotics
US4604239A (en) * 1982-03-24 1986-08-05 Eli Lilly And Company Antibiotics
US4713331A (en) * 1982-03-24 1987-12-15 Eli Lilly And Company Microbial production of A41030 antibiotics
US4695545A (en) * 1982-03-24 1987-09-22 Eli Lilly And Company Culture and process for producing A41030 antibiotics
US4559323A (en) * 1982-03-24 1985-12-17 Eli Lilly And Company A41030 Antibiotics
US4462942A (en) * 1982-07-30 1984-07-31 Eli Lilly And Company A47934 Antibiotic and process for production thereof
US4485102A (en) * 1982-08-16 1984-11-27 American Cyanamid Company High potency, mycelial-free avoparcin alkyl sulfate complex, and method for the preparation thereof
US4495179A (en) * 1982-12-20 1985-01-22 Eli Lilly And Company A51568 Antibiotic and process for producing thereof
GB2137087B (en) * 1983-03-18 1987-02-18 American Cyanamid Co Improving milk production
US4558008A (en) * 1983-12-13 1985-12-10 Eli Lilly And Company Process for production of A-51568B antibiotic
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB877732A (en) * 1958-08-12 1961-09-20 Lepetit Spa The antibiotic rifomycin, its components and methods of preparing same
US3061516A (en) * 1960-05-20 1962-10-30 Bristol Myers Co Telomycin and its production
US3132609A (en) * 1961-12-11 1964-05-12 Chesley Ind Inc Shelf structure

Also Published As

Publication number Publication date
GB1194365A (en) 1970-06-10
FR6697M (enExample) 1969-02-10
US3338786A (en) 1967-08-29
DE1617299B2 (de) 1981-04-23
MY7400019A (en) 1974-12-31
DE1617299A1 (de) 1970-03-19

Similar Documents

Publication Publication Date Title
DE1617299C3 (de) Glycopeptid-Antibiotikum AV 290 - Komplex (Avoparcin) Verfahren zu seiner Herstellung und seine Verwendung
DD204389A5 (de) Tierfuttermittel
DE2167325C2 (de) Antibiotikum A-201B und Verfahren zu seiner Herstellung
DE2209067A1 (de) Neue Antibiotika, ihre Herstellung und die medizinischen Zusammensetzungen, die sie enthalten
DE1217549B (de) Herstellung des neuen Antibiotikums Bleomycin
DE2737943C2 (de) Antibiotisch wirksames Oligosaccharid, Verfahren zu seiner Herstellung sowie dieses enthaltende Arzneimittel
DE2928373C2 (de) Antibiotika KA-7038I bis KA-7038VII, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibiotische Mittel
DE2450411C3 (enExample)
DE2233555C3 (de) Verfahren zur Herstellung von Spectinomycin
DE2034245C2 (de) Antibiotikum Juvenimicin A↓3↓
DE1926458A1 (de) Antibiotische Substanzen und Verfahren zu ihrer Herstellung
DE2039990C2 (de) Neue Antibiotika B-5050 A bis F (Maridomycin I bis VI), Verfahren zu ihrer Herstellung und ihre pharmazeutische Zubereitung
DE1667923C3 (de) Neue Antibiotika, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitung, die diese Antibiotika enthält
DE1767846C3 (de) Verfahren zur Gewinnung des Antibiotikums NK-1003 bestehend aus 4-O-(6-Amino-6-deoxy-ct-D-glucosyl)- deoxystreptamin
DE1793403C (de) Verfahren zur mikrobiolo gischen Herstellung von 2' Amino 2' deoxy kanamycin
DE1767847C3 (de) Antibiotikum, Verfahren zu seiner Herstellung und dieses Antibiotikum enthaltende Arzneipraparate
DE2351344A1 (de) Antibioticum bm 123 und verfahren zu seiner herstellung
DE1492111C (de) Verfahren zur Herstellung von Poly oxm A und B
DE2818544A1 (de) Antibiotikum sf-1942, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das antibiotikum sf-1942 enthaelt
AT226371B (de) Verfahren zur Herstellung einer neuartigen stickstoffhaltigen organischen Base und ihrer Säureadditionssalze
DE1089513B (de) Verfahren zur Herstellung des Antibiotikums Rifomycin und seiner Komponenten
DE1116862B (de) Herstellung und Gewinnung des Antibiotikums Aspartocin
DE2637545A1 (de) Antibiotica bm123 und ihre herstellung
DE2624084A1 (de) Antibiotica am31alpha, am31beta und am31gamma und verfahren zu ihrer herstellung
DE1184901B (de) Herstellung des Antibiotikums 1415

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8380 Miscellaneous part iii

Free format text: DER VERTRETER IST NACHZUTRAGEN PFENNING, J., DIPL.-ING. MAAS, I., DIPL.-CHEM. DR.RER.NAT. MEINIG, K., DIPL.-PHYS. SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT